The overall objective is to define the Ca2+-signaling pathways in macrophages that regulate functions of and genes involved in the inflammatory response. Obesity, Type 2 Diabetes and other disease states associated with the Metabolic Syndrome are inflammatory diseases characterized by infiltration of macrophages into metabolic tissue. We identified a CaM kinase cascade comprised of CaMKK2 and AMPK that regulates energy balance. Mice null for CaMKK2 are protected from the insulin resistance, glucose intolerance, obesity and liver steatosis that result from consuming a high fat diet. At least part of the protection is mediated via the central nervous system as CaMKK2 functions in neurons of the hypothalamic arcuate nucleus to control production of neuropeptide Y. However, the attenuated inflammatory response in the adipose tissues of obese CaMKK2 null mice led us to question whether there may also be a peripheral immune target for CaMKK2 and we found CaMKK2 is expressed in macrophages. Depletion of CaMKK2 from macrophages results in markedly attenuated response to the bacterial endotoxin, Lipopolysaccharide (LPS) that binds to and activates Toll-like receptor 4 (TLR4) and causes systemic inflammation. The altered macrophage responses include decreased inflammatory cytokine and chemokine gene expression and secretion, cell surface expression of co- stimulatory molecules, ability to phagocytose bacterial particles and motility. Accordingly, administration of a dose of LPS alone or in combination with N-galactosamine to CaMKK2 null mice that is lethal for WT mice results in a profound decrease in proinflammatory cytokines and chemokines in serum, reduced liver damage and well as markedly prolonged survival. We hypothesize that CaMKK2 plays a key role in mediating the cellular signals initiated by Toll-like receptors (TLRs), thereby affecting macrophage activation and inflammatory responses. To evaluate this hypothesis we will: 1) define the role of CaMKK2 in the activation of isolated macrophages by; (a) investigating the role of CaMKK2 in mechanisms regulating activation and de- activation of macrophages; (b) identifying targets of CaMKK2 critical for the responses to TLR4 agonists; (c) identify genes and transcription factors regulated by CaMKK2; and 2) define the role of CaMKK2 in the inflammatory response induced by over-nutrition by using conditional LysM-Cre/CaMKK2lox/lox, and conditional CaMKK2 Cre/lox mice already developed by our laboratory to; (a) determine if ablation of CaMKK2 in macrophages prevents inflammation of metabolic tissues and results in insulin sensitivity and glucose tolerance; (b) determine if the ablation of CaMKK2 reverses inflammation in metabolic tissues and restores insulin sensitivity and glucose tolerance. Because inflammation is such a prevalent cause of or response to numerous human diseases we believe our studies will reveal CaMKK2 to be an important, novel target for therapeutic intervention.

Public Health Relevance

We have uncovered a novel function for a calcium-activated protein kinase, CaMKK2, in mechanisms regulating the response of macrophages to stimuli that lead to inflammation. As macrophages play a pivotal role in the regulation of the inflammatory response, and in turn, in the pathogenesis of clinically relevant conditions associated with an inappropriate inflammatory response such as obesity, Type 2 Diabetes, and atherosclerosis, CaMKK2 may be a novel target for treatment of these immune disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM033976-30
Application #
8877557
Study Section
Integrative Physiology of Obesity and Diabetes Study Section (IPOD)
Program Officer
Melillo, Amanda A
Project Start
1984-07-01
Project End
2017-06-30
Budget Start
2015-07-01
Budget End
2017-06-30
Support Year
30
Fiscal Year
2015
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Lannon, Sophia M R; Adams Waldorf, Kristina M; Fiedler, Tina et al. (2018) Parallel detection of lactobacillus and bacterial vaginosis-associated bacterial DNA in the chorioamnion and vagina of pregnant women at term. J Matern Fetal Neonatal Med :1-9
York, Brian; Li, Feng; Lin, Fumin et al. (2017) Pharmacological inhibition of CaMKK2 with the selective antagonist STO-609 regresses NAFLD. Sci Rep 7:11793
Marcelo, Kathrina L; Ribar, Thomas; Means, Christopher R et al. (2016) Research Resource: Roles for Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CaMKK2) in Systems Metabolism. Mol Endocrinol 30:557-72
Fleet, Tiffany; Stashi, Erin; Zhu, Bokai et al. (2016) Genetic and Environmental Models of Circadian Disruption Link SRC-2 Function to Hepatic Pathology. J Biol Rhythms 31:443-60
Marcelo, Kathrina L; Means, Anthony R; York, Brian (2016) The Ca(2+)/Calmodulin/CaMKK2 Axis: Nature's Metabolic CaMshaft. Trends Endocrinol Metab 27:706-718
Koh, Eun Hee; Chen, Yong; Bader, David A et al. (2016) Mitochondrial Activity in Human White Adipocytes Is Regulated by the Ubiquitin Carrier Protein 9/microRNA-30a Axis. J Biol Chem 291:24747-24755
Scott, John W; Park, Elizabeth; Rodriguiz, Ramona M et al. (2015) Autophosphorylation of CaMKK2 generates autonomous activity that is disrupted by a T85S mutation linked to anxiety and bipolar disorder. Sci Rep 5:14436
Fleet, Tiffany; Zhang, Bin; Lin, Fumin et al. (2015) SRC-2 orchestrates polygenic inputs for fine-tuning glucose homeostasis. Proc Natl Acad Sci U S A 112:E6068-77
Hartig, Sean M; Bader, David A; Abadie, Kathleen V et al. (2015) Ubc9 Impairs Activation of the Brown Fat Energy Metabolism Program in Human White Adipocytes. Mol Endocrinol 29:1320-33
Zhu, Bokai; Gates, Leah A; Stashi, Erin et al. (2015) Coactivator-Dependent Oscillation of Chromatin Accessibility Dictates Circadian Gene Amplitude via REV-ERB Loading. Mol Cell 60:769-783

Showing the most recent 10 out of 94 publications